Gefitinib Targets ZAP-70-expressing Chronic Lymphocytic Leukemia Cells and Inhibits B-Cell Receptor Signaling

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2014.391
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Metformin Inhibits Cell Cycle Progression of B-Cell Chronic Lymphocytic Leukemia Cells

Oncotarget
Oncology
2015English

The Outcome of B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia: Proliferation or Anergy

Haematologica
Hematology
2014English

Constitutive Activation of the B Cell Receptor Underlies Dysfunctional Signaling in Chronic Lymphocytic Leukemia

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

CXCL12-induced Chemotaxis Is Impaired in T Cells From Patients With ZAP-70-negative Chronic Lymphocytic Leukemia

Haematologica
Hematology
2010English

Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Gene Expression Signatures Separate B-Cell Chronic Lymphocytic Leukaemia Prognostic Subgroups Defined by ZAP-70 and CD38 Expression Status

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Interdomain B in ZAP-70 Regulates but Is Not Required for ZAP-70 Signaling Function in Lymphocytes

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1999English

Cytotoxic Lymphocytes in B-Cell Chronic Lymphocytic Leukemia

Annals of Hematology
MedicineHematology
1990English

B-Cell Receptor Translocation to Lipid Rafts and Associated Signaling Differ Between Prognostically Important Subgroups of Chronic Lymphocytic Leukemia

Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy